Literature DB >> 26112921

Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.

Raymond J Kelleher1, Sathy Balu-Iyer2, Jenni Loyall1, Anthony J Sacca1, Gautam N Shenoy1, Peng Peng1, Vandana Iyer2, Anas M Fathallah2, Charles S Berenson3, Paul K Wallace4, Joseph Tario4, Kunle Odunsi5, Richard B Bankert6.   

Abstract

The identification of immunosuppressive factors within human tumor microenvironments, and the ability to block these factors, would be expected to enhance patients' antitumor immune responses. We previously established that an unidentified factor, or factors, present in ovarian tumor ascites fluids reversibly inhibited the activation of T cells by arresting the T-cell signaling cascade. Ultracentrifugation of the tumor ascites fluid has now revealed a pellet that contains small extracellular vesicles (EV) with an average diameter of 80 nm. The T-cell arrest was determined to be causally linked to phosphatidylserine (PS) that is present on the outer leaflet of the vesicle bilayer, as a depletion of PS-expressing EV or a blockade of PS with anti-PS antibody significantly inhibits the vesicle-induced signaling arrest. The inhibitory EV were also isolated from solid tumor tissues. The presence of immunosuppressive vesicles in the microenvironments of ovarian tumors and our ability to block their inhibition of T-cell function represent a potential therapeutic target for patients with ovarian cancer. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26112921      PMCID: PMC4636911          DOI: 10.1158/2326-6066.CIR-15-0086

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  50 in total

1.  Dynamics of membrane translocation of phosphatidylserine during apoptosis detected by a monoclonal antibody.

Authors:  M Mourdjeva; D Kyurkchiev; A Mandinova; I Altankova; I Kehayov; S Kyurkchiev
Journal:  Apoptosis       Date:  2005-01       Impact factor: 4.677

2.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

3.  IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells.

Authors:  Lori Broderick; Stephen P Brooks; Hiroshi Takita; Alan N Baer; Joel M Bernstein; Richard B Bankert
Journal:  Clin Immunol       Date:  2005-11-03       Impact factor: 3.969

4.  T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha.

Authors:  Yuanyuan Zha; Reinhard Marks; Allen W Ho; Amy C Peterson; Sujit Janardhan; Ian Brown; Kesavannair Praveen; Stacey Stang; James C Stone; Thomas F Gajewski
Journal:  Nat Immunol       Date:  2006-10-08       Impact factor: 25.606

5.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

Authors:  Jeong Whun Kim; Eva Wieckowski; Douglas D Taylor; Torsten E Reichert; Simon Watkins; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

6.  Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Authors:  Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; William H Sharfman; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; Marta M Gilson; Changyu Wang; Mark Selby; Janis M Taube; Robert Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne L Topalian
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

7.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

8.  Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

Authors:  Mark V Thornton; Daisuke Kudo; Patricia Rayman; Claudine Horton; Luis Molto; Martha K Cathcart; Christopher Ng; Ewa Paszkiewicz-Kozik; Ronald Bukowski; Ithaar Derweesh; Charles S Tannenbaum; James H Finke
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

9.  Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.

Authors:  Xiao-Ping Zhong; Ehmonie A Hainey; Benjamin A Olenchock; Martha S Jordan; Jonathan S Maltzman; Kim E Nichols; Hao Shen; Gary A Koretzky
Journal:  Nat Immunol       Date:  2003-07-27       Impact factor: 25.606

Review 10.  Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).

Authors:  Theresa L Whiteside
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

View more
  46 in total

1.  Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses.

Authors:  Gautam N Shenoy; Jenni Loyall; Orla Maguire; Vandana Iyer; Raymond J Kelleher; Hans Minderman; Paul K Wallace; Kunle Odunsi; Sathy V Balu-Iyer; Richard B Bankert
Journal:  Cancer Immunol Res       Date:  2018-01-04       Impact factor: 11.151

Review 2.  Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.

Authors:  Thinle Chodon; Amit A Lugade; Sebastiano Battaglia; Kunle Odunsi
Journal:  Hematol Oncol Clin North Am       Date:  2018-10-01       Impact factor: 3.722

Review 3.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

4.  Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.

Authors:  J Brian Szender; Tiffany Emmons; Sarah Belliotti; Danielle Dickson; Aalia Khan; Kayla Morrell; A N M Nazmul Khan; Kelly L Singel; Paul C Mayor; Kirsten B Moysich; Kunle Odunsi; Brahm H Segal; Kevin H Eng
Journal:  Gynecol Oncol       Date:  2017-06-16       Impact factor: 5.482

5.  Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Authors:  Gautam N Shenoy; Jenni Loyall; Charles S Berenson; Raymond J Kelleher; Vandana Iyer; Sathy V Balu-Iyer; Kunle Odunsi; Richard B Bankert
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

6.  Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Jenni L Loyall; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  Immunol Invest       Date:  2020-04-17       Impact factor: 3.657

Review 7.  Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.

Authors:  Fiona Y Glassman; Robert Dingman; Helena C Yau; Sathy V Balu-Iyer
Journal:  Immunol Invest       Date:  2020-03-23       Impact factor: 3.657

8.  Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.

Authors:  Fiona Y Glassman; Jennifer L Schneider; Radha Ramakrishnan; Robert K Dingman; Murali Ramanathan; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-04-09       Impact factor: 3.534

9.  Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma.

Authors:  Bruce D Freimark; Jian Gong; Dan Ye; Michael J Gray; Van Nguyen; Shen Yin; Michaela M S Hatch; Christopher C W Hughes; Alan J Schroit; Jeff T Hutchins; Rolf A Brekken; Xianming Huang
Journal:  Cancer Immunol Res       Date:  2016-04-04       Impact factor: 11.151

10.  VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.

Authors:  Irina V Tiper; Sarah M Temkin; Sarah Spiegel; Simeon E Goldblum; Robert L Giuntoli; Mathias Oelke; Jonathan P Schneck; Tonya J Webb
Journal:  Clin Cancer Res       Date:  2016-04-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.